 Vancouver Sun | Health Highlights: May 7, 2013 - Philly.com Philly.com A potential new drug for Alzheimer's disease failed to slow patients' mental or physical decline, drug maker Baxter International Inc. says. A study of 390 patients with mild to moderate Alzheimer's disease found that those who received 18 months of infusions ... Blow for Alzheimer's patients as 'best hope drug' fails final trials Baxter's Alzheimer's disease drug fails in late-stage trial This Contradiction In Baxter's Data Will Make Alzheimer's Researchers Nervous |
Facebook
Twitter
Pinterest
Instagram
Google+
YouTube
LinkedIn
RSS